MRI scans are strong diagnostics with high-definition images of what lies inside a body. Strong magnetic fields require precaution, as brought out by an instance where a young woman suffered very serious injuries due to an oversight in a metallic core within a silicone sex toy that she happened to have before the MRI scan. This makes a stark reminder about the potentially deadly consequences of missing metal objects when such procedures are being performed. In April 2023, a 23-year-old woman went into an MRI with a silicone plug containing a metal core that was not known.
She thought that the item is made entirely out of silicone according to the advertising. However, the strong magnetic field of the MRI machine interacted with the hidden metal, dragging the object through her body and causing excruciating pain. According to reports from the U.S. Food and Drug Administration (FDA), the scene was harrowing, with the woman screaming in agony and requiring immediate hospitalization. Despite pre-scan screenings, which are routine prior to a scan, the patient did not inform the facility that the object existed because he presumed it was purely non-metallic. This caused serious injuries that led to the patient's law suit against the manufacturer for deceitful misrepresentations of material content.
MRI machines employ magnets between 0.5 to 3 Tesla (T). This is thousands of times stronger than the Earth's magnetic field. The tremendous force causes ferromagnetic materials, like iron and nickel, to be magnetized quickly and become strongly attracted toward the magnet. Objects as small as hairpins or paper clips will accelerate at 40 miles per hour inside the magnetic field.
The force can lead to catastrophic injuries in items lodged within the body, such as metallic implants or foreign objects. Metallic cores within devices, like pacemakers or intrauterine devices, must be disclosed to radiologists to prevent such complications.
On these claims, Dr. Adam Taylor, a specialist in human anatomy, weighed his words in a international health website and added that the distance away and mass of this object would increase its velocity towards that of sound, "The acceleration would be phenomenal, but with a metallic core, it can't go anywhere near supersonic speeds. As for the size, the magnetic acceleration to the internal soft tissues would ensure that there could be severe intracranial trauma."
The injuries inflicted in this case likely involved damage to major blood vessels, nerves, or organs, highlighting the devastating impact of even minor oversight during an MRI scan.
This is not an isolated case. There are documented cases of metallic objects causing serious damage during MRI scans with a 65-year-old man with schizophrenia swallowed metal objects, including sockets and a hinge pin. The powerful magnetic field during an MRI scan caused the objects to rupture his stomach, resulting in serious injuries.
A toddler who ingested 11 small magnets perforated his bowel while undergoing a scan, making his case unique. In another deadly but extremely rare incident, there have been people who hide a firearm on themselves during MRI procedures. Magnetic attraction can trigger a discharge in a weapon and has led to some fatal injuries.
These cases emphasize the very strong need for adequate screening and patient education prior to an MRI.
Medical professionals have been trained to avoid risks. This is by properly screening a patient for metallic objects. In general, most pre-scan protocols include:
The case emphasizes the importance of product labeling by manufacturers, especially those products that are likely to unintentionally cause harm to health. The patient's assumption that her device was 100% silicone points to a larger problem in consumer markets with misinformation.
It also reminds the patients to report any possible dangers to the medical professionals, no matter how the objects look non-metallic. In sensitive cases, patients can request private discussions with healthcare providers to ensure safety without discomfort.
In the end, it is a joint effort from manufacturers, healthcare professionals, and patients that can prevent such tragedies. Manufacturers must ensure truthful marketing, while healthcare providers should educate patients about the dangers of metal objects in MRI settings. For patients, understanding the risks and actively participating in pre-scan disclosures can be lifesaving.
This young woman's experience is a sobering example of the unforeseen dangers posed by MRI machines when precautions are overlooked. It serves as a wake-up call to address gaps in patient awareness, medical protocols, and product transparency. By learning from this incident, the medical community and the public can work together to ensure MRI scans remain a safe and effective diagnostic tool.
Credit: AI-generated image
Breckenridge Pharmaceutical, Inc. has announced a voluntary nationwide recall of a batch of Propranolol Hydrochloride Extended-Release Capsules, USP 60 mg in the US over concerns that the medication may contain metal particles.
The recall, announced on November 16, 2026, covers one lot of the blood pressure medication manufactured by Adare Pharma Solutions. The company initiated the recall after identifying a possible contamination linked to an intermediate material used in the affected batch.
According to the company's recall notice, the contaminated material was suspected to be the source of metal contamination identified in a separate lot that was not released into the market.
The company has warned that taking capsules from the affected lot could cause physical injuries to soft tissues in the body.
According to the recall notice, use of the affected product could cause "lacerations of soft tissues in the oral cavity, esophagus, stomach, or intestine."
However, Breckenridge Pharmaceutical stated that it was not aware of any adverse events related to the recall at the time of the announcement.
The affected products were distributed to wholesalers and pharmacies across the US between October 26 and November 4, 2026.
Also read: From 4 To 100 Kratom Capsules A Day: Woman Shares Warning Signs Of Addiction
The recall is limited to a specific batch of 60 mg Propranolol Hydrochloride Extended-Release Capsules. The details are:
Those who have been prescribed the pill between the dates mentioned above are advised to check the product packaging and lot number to determine whether their medication is part of the recall.
Also read: Popular Anti-Anxiety Capsules Recalled Over Salmonella Fears: What Should Patients Know
Breckenridge Pharmaceutical has advised consumers to immediately stop taking the medication from the affected lot and contact their physician or healthcare provider for medical advice for obtaining a replacement.
"Consumers should return any unused portion of the affected product to the pharmacy where it was obtained," the company's announcement said.
Patients should also return any unused capsules from the recalled batch to the pharmacy where they purchased the medication. Anyone who has experienced health problems that could be due to the recalled medicine should contact their healthcare provider.
Pharmacies, wholesalers and other retailers have been instructed to check their inventories, quarantine the affected products and stop distributing or dispensing them.
Consumers seeking additional information about the recall can contact Qualanex, the company's designated recall service provider, at 1-855-736-0807 or email recall@qualanex.com. The recall is being conducted with the knowledge of the US Food and Drug Administration (FDA).
Also read: US FDA Recalls Thousands Of Blood Pressure Drugs Over Excess Drug Levels, Failed Quality Tests
Propranolol belongs to a class of medicines called beta-blockers. It works by reducing the effects of certain stress hormones on the heart, thereby slowing the heart rate and reducing blood pressure.
The medication is commonly prescribed to manage high blood pressure and other cardiovascular conditions. It is also used for certain heart rhythm disorders, angina and migraine prevention.
The extended-release formulation is designed to release the medicine gradually over time, allowing effects that last long.
Propranolol's recall is the latest in a series of recent blood pressure medication recalls, including a recent one involving Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets. They were recalled as they did not dissolve properly. A while go, Chlorthalidone tablets were also recalled for the same reason.
Credit: iStock
Could chewing gum one day help fight cancer? Researchers at the University of Pennsylvania in the US have developed an experimental gum made from lablab beans, also known as Indian beans, that targets human papillomavirus (HPV) and harmful oral bacteria associated with head and neck cancer.
In laboratory tests using oral samples from cancer patients, extracts of the gum reduced HPV levels by up to 93%. An enhanced version also reduced two harmful bacterial species to nearly undetectable levels without affecting the beneficial bacteria tested.
The experimental gum builds on the team's earlier research into lablab beans. It contains FRIL, a naturally occurring plant protein with antiviral properties.
Researchers tested gum extracts against microorganisms in oral samples collected from patients with head and neck cancer.
The results published in Scientific Reports journal showed:
The researchers also developed an enhanced version containing protegrin, an antimicrobial peptide. Peptides are short chains of amino acids, the building blocks of proteins.
A single dose of the enhanced gum extract reduced two targeted bacterial species, Porphyromonas gingivalis (Pg) and Fusobacterium nucleatum (Fn), to nearly undetectable levels.
Also read: HPV Vaccines Can Prevent Head And Neck Cancers In Men, Says Study
The experimental formulation selectively targeted harmful bacteria while leaving the beneficial bacterial populations examined in the study largely unaffected.
The oral microbiome, which consists of microorganisms living inside the mouth, plays an important role in maintaining oral health.
Cancer treatments such as radiation therapy can disrupt this microbial balance, reducing beneficial bacteria and encouraging the growth of potentially harmful microorganisms, including Candida albicans, a type of yeast.
The researchers suggest that selectively targeting harmful microbes while preserving beneficial ones could be particularly useful for patients undergoing cancer treatment.
Read More: Russia's mRNA Cancer Vaccine: First Patient With Melanoma Completes Treatment, Shows No New Tumours
The researchers believe the findings warrant further investigation through human clinical trials. They envision the technology potentially being used alongside existing cancer treatments or as a preventive approach to limit infections.
"Lip and oral cavity cancer was the seventh leading cancer type in cancer incidence and mortality rate worldwide in adolescents, young adults, and middle-aged adults in 2022," Daniell said.
He said the findings support advancing these therapies into clinical trials as additional treatments or as prophylaxis to prevent infection and transmission.
Prophylaxis refers to measures taken to prevent a disease or infection before it occurs.
The plant-based technology could also offer a potentially affordable way to deliver protective proteins directly into the mouth.
However, the findings should be interpreted cautiously. The researchers tested gum extracts on patient samples under laboratory conditions. They have not established whether chewing the gum produces the same results in people or whether reducing these microorganisms can prevent cancer or improve treatment outcomes.
Human clinical trials will be needed to establish its safety and effectiveness. For now, the bean-based gum remains experimental and is not a proven cancer-prevention or treatment option.
Credit: iStock
With one in six laboratory-confirmed bacterial infections worldwide already resistant to antibiotics, drug-resistant infections could contribute to more than 39 million deaths by 2050 if current trends persist, according to the World Health Organization (WHO).
Speaking at the virtual 6th Annual Global Media Forum on AMR, WHO officials warned that countries are not doing enough to tackle antimicrobial resistance (AMR), despite growing commitments. They also presented findings from the latest joint survey by WHO, the United Nations Environment Programme, the World Organisation for Animal Health and the Food and Agriculture Organization.
Although more countries have adopted national action plans to combat AMR, most have failed to translate these commitments into funded and implemented programmes. As a result, the world remains off track to meet key 2030 targets.
Of the 183 countries surveyed, 173 reported having a national action plan, up from 79 in 2017. However, only 42 said their plans were financed and implemented.
Also read: Over One In Four Americans Lied To Get Antibiotics For Children: Why It Can Be Dangerous
Antimicrobial resistance occurs when bacteria, viruses, fungi and parasites evolve and no longer respond to medicines designed to treat them. This makes infections harder to treat and increases the risk of disease spread, severe illness and death.
Antibiotic resistance is a form of AMR that specifically involves bacteria becoming resistant to antibiotics. Misuse and overuse of these medicines accelerate the problem.
At the 2024 United Nations General Assembly, countries agreed on a series of targets to tackle AMR by 2030. However, experts warn that the growing threat could undermine decades of medical progress.
"Procedures we now take for granted become far riskier when antibiotics and antimicrobials no longer work," Jean-Pierre Nyemazi, acting director of WHO's AMR department, said. The development of new antibiotics is also failing to keep pace with the spread of resistance, he added, Reuters reported.
"Unlike COVID-19, which was very visible, drug-resistant infections have been taking people's lives for years without us noticing it and raising the alarm as we should," Nyemazi said at the forum.
In 2021 alone, AMR was directly responsible for more than one million deaths and associated with approximately 4.7 million others, according to WHO figures.
The 2026 survey highlighted major gaps in infection prevention, a key measure for reducing the need for antibiotics.
The WHO reported that 128 countries now have national infection prevention and control programmes and guidelines, up from 90 in 2018. However, only 69 countries, or 38%, have implemented these programmes nationwide, well below the 2030 target of 90%.
Read More: 98 Years After Penicillin: Are We Running Out Of Effective Antibiotics?
Laboratory capacity also remains limited. While 131 countries reported having national reference laboratories capable of testing antibiotic resistance in common bacteria, only 66 could test for both bacterial and fungal resistance. Countries have agreed to ensure that 80% have these capabilities by 2030.
The WHO also released two toolkits to help countries strengthen diagnostic capacity, covering essential tests and laboratory procedures.
Surveillance has improved, with 113 countries now monitoring antibiotic use and 109 tracking antimicrobial resistance, compared with 65 and 39, respectively, in 2017.
However, only 21 countries reported integrating data on antibiotic use and resistance. The WHO said combining these datasets is essential to understand how antibiotic consumption drives resistance and to guide efforts to contain it.
Antibiotics treat bacterial infections but do not work against viral infections, which commonly cause cold- and flu-like symptoms. Unnecessary use can also expose patients to side effects and contribute to antimicrobial resistance.
As per the WHO, resistance exists across 22 different antibiotics—the common drugs used to treat everyday illnesses, such as:
When bacteria develop resistance, infections become harder to treat, increasing the risk of complications and limiting available treatment options.
(With inputs from agencies)
© $2026 Times Horizon Private Limited